Skip to content

Medical emergency? What to do

Glycogen phosphorylase inhibition can impair aerobic muscle function in type 2 diabetes

3-RXPublished September 19, 20062 min read

Key points

  • Glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction in type 2 diabetic patients.
  • Baker and colleagues at the Karolinska Institute found, "Skeletal muscle energy metabolism and function are not impaired by GPi during high-intensity contraction in rat skeletal muscle; however, it is unknown whether glycogen phosphorylase inhibitors would impair function during prolonged lower-intensity contraction.
  • "Our data," concluded the authors, "provide new confirmation that muscle glycogen plays an essential role during submaximal contraction.
  • Publisher contact information for the journal Diabetes is: American Diabetes Association, 1701 N Beauregard St., Alexandria, VA 22311-1717, USA.

Glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction in type 2 diabetic patients.

According to recent research from Sweden, "Glycogen phosphorylase inhibition represents a promising strategy to suppress inappropriate hepatic glucose output, while muscle glycogen is a major source of fuel during contraction. Glycogen phosphorylase inhibitors (GPi) currently being investigated for the treatment of type 2 diabetes do not demonstrate hepatic versus muscle glycogen phosphorylase isoform selectivity and may therefore impair patient aerobic exercise capabilities."

D.J. Baker and colleagues at the Karolinska Institute found, "Skeletal muscle energy metabolism and function are not impaired by GPi during high-intensity contraction in rat skeletal muscle; however, it is unknown whether glycogen phosphorylase inhibitors would impair function during prolonged lower-intensity contraction. Utilizing a novel red cell-perfused rodent gastrocnemius-plantaris-soleus system, muscle was pretreated for 60 min with either 3 mcmol/L free drug GPi (n=8) or vehicle control (n=7).

"During 60 min of aerobic contraction, GPi treatment resulted in similar to 35% greater fatigue. Muscle glycogen phosphorylase a form (p<0.01) and maximal activity (p<0.01) were reduced in the GPi group, and postcontraction glycogen (121.8(plusminus)16.1 vs. 168.3 (plusminus)8.5 mmol/kg dry muscle, p<0.05) was greater. Furthermore, lower muscle lactate efflux and glucose uptake (p<0.01), yet higher muscle Vo[2], support the conclusion that carbohydrate utilization was impaired during contraction."

"Our data," concluded the authors, "provide new confirmation that muscle glycogen plays an essential role during submaximal contraction. Given the critical role of exercise prescription in the treatment of type 2 diabetes, it will be important to monitor endurance capacity during the clinical evaluation of nonselective Gpi. Alternatively, greater effort should be devoted toward the discovery of hepatic-selective GPi, hepatic-specific drug delivery strategies, and/or alternative strategies for controlling excess hepatic glucose production in type 2 diabetes."

Baker and colleagues published their study in Diabetes (The experimental type 2 diabetes therapy glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction. Diabetes, 2006;55(6):1855-1861).

For additional information, contact J.A. Timmons, Karolinska Institute, Center General & Bioinformat, Berzelius Vag 35, S-17177 Stockholm, Sweden.

Publisher contact information for the journal Diabetes is: American Diabetes Association, 1701 N Beauregard St., Alexandria, VA 22311-1717, USA.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDiabetes

Keep reading

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.